PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
26,618,439
Share change
-1,236,085
Total reported value
$27,133,000
Put/Call ratio
130%
Price per share
$1.02
Number of holders
27
Value change
-$2,963,264
Number of buys
16
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q4 2015

As of 31 Dec 2015, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,618,439 shares. The largest 10 holders included Camber Capital Management LLC, BAILLIE GIFFORD & CO, Broadfin Capital, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BARCLAYS PLC, BRIDGEWAY CAPITAL MANAGEMENT INC, DEUTSCHE BANK AG\, STATE OF WISCONSIN INVESTMENT BOARD, Spark Investment Management LLC, and JANE STREET GROUP, LLC. This page lists 27 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.